Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00268762 · ClinicalTrials.gov registry record · Phase 1
Argatroban Stroke Treatment - A Pilot Safety Study
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00268762 is a Phase 1 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 65 participants.
The verdict
NCT00268762, a Phase 1 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
Is the combination of low doses of argatroban in combination with rt-PA safe, and does it increase recanalization in patients with acute ischemic stroke.
Interventions
- DRUG argatroban
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2003-02 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00268762
The ClinicalTrials.gov registry entry for NCT00268762 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which argatroban is the first listed.
NCT00268762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00268762 about?
NCT00268762 is a clinical study titled "Argatroban Stroke Treatment - A Pilot Safety Study". Is the combination of low doses of argatroban in combination with rt-PA safe, and does it increase recanalization in patients with acute ischemic stroke.
What is the current status of trial NCT00268762?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2003-02. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00268762?
The interventions under investigation include: argatroban (DRUG).
Who is sponsoring clinical trial NCT00268762?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.